Report cover image

Dysmenorrhea Treatment Market by Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), Treatment (Medication, Surgery, Therapy), Diagnosis, Mode of Prescription, Route of Administration, End-Users - Global Forecast 2023-2030

Publisher 360iResearch
Published Oct 04, 2023
Length 190 Pages
SKU # IRE18316093

Description

Dysmenorrhea Treatment Market by Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), Treatment (Medication, Surgery, Therapy), Diagnosis, Mode of Prescription, Route of Administration, End-Users - Global Forecast 2023-2030


The Dysmenorrhea Treatment Market size was estimated at USD 6.02 billion in 2022 and expected to reach USD 6.61 billion in 2023, at a CAGR 10.32% to reach USD 13.21 billion by 2030 .

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Dysmenorrhea Treatment Market.
  • Based on Type, market is studied across Primary Dysmenorrhea and Secondary Dysmenorrhea. The Secondary Dysmenorrhea is projected to witness significant market share during forecast period.
  • Based on Treatment, market is studied across Medication, Surgery, and Therapy. The Therapy is projected to witness significant market share during forecast period.
  • Based on Diagnosis, market is studied across CT Scan, Laparoscopy, Magnetic Resonance Imaging, and Ultrasound. The Ultrasound is projected to witness significant market share during forecast period.
  • Based on Mode of Prescription, market is studied across Over the Counter and Prescription. The Prescription is projected to witness significant market share during forecast period.
  • Based on Route of Administration, market is studied across Implants, Oral, and Parenteral. The Parenteral is projected to witness significant market share during forecast period.
  • Based on End-Users, market is studied across Homecare, Hospitals, and Specialty Clinics. The Homecare is projected to witness significant market share during forecast period.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Dysmenorrhea Treatment Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Dysmenorrhea Treatment Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Dysmenorrhea Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alvogen, Bayer AG, Cora Life, F. Hoffmann-La Roche Ltd., Focus Consumer Healthcare, GlaxoSmithKline PLC, Merck KGaA, Novartis AG, Nua, Pfizer Inc., Reckitt Benckiser Group PLC, Sanofi, Taj Pharmaceuticals Limited, and Vanita's Rehab.

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Dysmenorrhea Treatment Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Dysmenorrhea Treatment Market?
  3. What is the competitive strategic window for identifying opportunities in the Dysmenorrhea Treatment Market?
  4. What are the latest technology trends and regulatory frameworks in the Dysmenorrhea Treatment Market?
  5. What is the market share of the leading vendors in the Dysmenorrhea Treatment Market?
  6. Which modes and strategic moves are suitable for entering the Dysmenorrhea Treatment Market?


Note: PDF & Excel + Online Access - 1 Year

Table of Contents

190 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Dysmenorrhea Treatment Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of dysmenorrhea among adolescent girls
5.1.1.2. Increasing number of government measures to raise awareness
5.1.1.3. Growing geriatric population leads to use dysmenorrhea treatment
5.1.2. Restraints
5.1.2.1. Associated side effects and complications with dysmenorrhea treatment
5.1.3. Opportunities
5.1.3.1. Innovations in management of dysmenorrhea
5.1.3.2. Ongoing research and development activities
5.1.4. Challenges
5.1.4.1. Limited awareness about reproductive health in women
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Dysmenorrhea Treatment Market, by Type
6.1. Introduction
6.2. Primary Dysmenorrhea
6.3. Secondary Dysmenorrhea
7. Dysmenorrhea Treatment Market, by Treatment
7.1. Introduction
7.2. Medication
7.3. Surgery
7.4. Therapy
8. Dysmenorrhea Treatment Market, by Diagnosis
8.1. Introduction
8.2. CT Scan
8.3. Laparoscopy
8.4. Magnetic Resonance Imaging
8.5. Ultrasound
9. Dysmenorrhea Treatment Market, by Mode of Prescription
9.1. Introduction
9.2. Over the Counter
9.3. Prescription
10. Dysmenorrhea Treatment Market, by Route of Administration
10.1. Introduction
10.2. Implants
10.3. Oral
10.4. Parenteral
11. Dysmenorrhea Treatment Market, by End-Users
11.1. Introduction
11.2. Homecare
11.3. Hospitals
11.4. Specialty Clinics
12. Americas Dysmenorrhea Treatment Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Dysmenorrhea Treatment Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Dysmenorrhea Treatment Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.2. Market Share Analysis, By Key Player
15.3. Competitive Scenario Analysis, By Key Player
16. Competitive Portfolio
16.1. Key Company Profiles
16.1.1. Abbott Laboratories
16.1.2. Alvogen
16.1.3. Bayer AG
16.1.4. Cora Life
16.1.5. F. Hoffmann-La Roche Ltd.
16.1.6. Focus Consumer Healthcare
16.1.7. GlaxoSmithKline PLC
16.1.8. Merck KGaA
16.1.9. Novartis AG
16.1.10. Nua
16.1.11. Pfizer Inc.
16.1.12. Reckitt Benckiser Group PLC
16.1.13. Sanofi
16.1.14. Taj Pharmaceuticals Limited
16.1.15. Vanita's Rehab
16.2. Key Product Portfolio
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us